| Characteristic . | Patients . |
|---|---|
| N = 1132 . | |
| Age (years) | 70.1 ± 8.9 |
| Male sex | 854 (75.4%) |
| Body surface area (m2) | 2.0 ± 0.2 |
| NYHA class | |
| I | 126 (11.1%) |
| II | 533 (47.1%) |
| III | 451 (39.8%) |
| IV | 22 (1.9%) |
| STS risk of mortality (%) | 2.0 ± 1.4 |
| History of atrial fibrillation | 119/1125 (10.6%) |
| Paroxysmal | 72/1125 (6.4%) |
| Persistent | 32/1125 (2.8%) |
| Long-standing persistent | 15/1125 (1.3%) |
| Unknown | 7 |
| Congestive heart failure | 224 (19.8%) |
| Coronary artery disease | 496 (43.8%) |
| Diabetes | 303 (26.8%) |
| Dyslipidaemia | 698 (61.7%) |
| Prior endocarditis | 4 (0.4%) |
| Hypertension | 861 (76.1%) |
| Left ventricular hypertrophy | 459 (40.5%) |
| Myocardial infarction | 100 (8.8%) |
| Renal dysfunction/insufficiency | 120 (10.6%) |
| Stroke/cerebrovascular accident | 46 (4.1%) |
| Transient ischaemic attack | 61 (5.4%) |
| Coronary artery bypass | 25 (2.2%) |
| Percutaneous coronary intervention | 161 (14.2%) |
| Stent implanted | 153 (13.5%) |
| Implanted cardiac device (i.e. pacemaker or defibrillator) | 39 (3.4%) |
| Previous open-heart surgerya | 40 (3.5%) |
| Characteristic . | Patients . |
|---|---|
| N = 1132 . | |
| Age (years) | 70.1 ± 8.9 |
| Male sex | 854 (75.4%) |
| Body surface area (m2) | 2.0 ± 0.2 |
| NYHA class | |
| I | 126 (11.1%) |
| II | 533 (47.1%) |
| III | 451 (39.8%) |
| IV | 22 (1.9%) |
| STS risk of mortality (%) | 2.0 ± 1.4 |
| History of atrial fibrillation | 119/1125 (10.6%) |
| Paroxysmal | 72/1125 (6.4%) |
| Persistent | 32/1125 (2.8%) |
| Long-standing persistent | 15/1125 (1.3%) |
| Unknown | 7 |
| Congestive heart failure | 224 (19.8%) |
| Coronary artery disease | 496 (43.8%) |
| Diabetes | 303 (26.8%) |
| Dyslipidaemia | 698 (61.7%) |
| Prior endocarditis | 4 (0.4%) |
| Hypertension | 861 (76.1%) |
| Left ventricular hypertrophy | 459 (40.5%) |
| Myocardial infarction | 100 (8.8%) |
| Renal dysfunction/insufficiency | 120 (10.6%) |
| Stroke/cerebrovascular accident | 46 (4.1%) |
| Transient ischaemic attack | 61 (5.4%) |
| Coronary artery bypass | 25 (2.2%) |
| Percutaneous coronary intervention | 161 (14.2%) |
| Stent implanted | 153 (13.5%) |
| Implanted cardiac device (i.e. pacemaker or defibrillator) | 39 (3.4%) |
| Previous open-heart surgerya | 40 (3.5%) |
Data are mean ± SD or n (%).
No patient had >1 prior open-heart surgery.
NYHA: New York Heart Association; SD: standard deviation; STS: Society of Thoracic Surgeons.
| Characteristic . | Patients . |
|---|---|
| N = 1132 . | |
| Age (years) | 70.1 ± 8.9 |
| Male sex | 854 (75.4%) |
| Body surface area (m2) | 2.0 ± 0.2 |
| NYHA class | |
| I | 126 (11.1%) |
| II | 533 (47.1%) |
| III | 451 (39.8%) |
| IV | 22 (1.9%) |
| STS risk of mortality (%) | 2.0 ± 1.4 |
| History of atrial fibrillation | 119/1125 (10.6%) |
| Paroxysmal | 72/1125 (6.4%) |
| Persistent | 32/1125 (2.8%) |
| Long-standing persistent | 15/1125 (1.3%) |
| Unknown | 7 |
| Congestive heart failure | 224 (19.8%) |
| Coronary artery disease | 496 (43.8%) |
| Diabetes | 303 (26.8%) |
| Dyslipidaemia | 698 (61.7%) |
| Prior endocarditis | 4 (0.4%) |
| Hypertension | 861 (76.1%) |
| Left ventricular hypertrophy | 459 (40.5%) |
| Myocardial infarction | 100 (8.8%) |
| Renal dysfunction/insufficiency | 120 (10.6%) |
| Stroke/cerebrovascular accident | 46 (4.1%) |
| Transient ischaemic attack | 61 (5.4%) |
| Coronary artery bypass | 25 (2.2%) |
| Percutaneous coronary intervention | 161 (14.2%) |
| Stent implanted | 153 (13.5%) |
| Implanted cardiac device (i.e. pacemaker or defibrillator) | 39 (3.4%) |
| Previous open-heart surgerya | 40 (3.5%) |
| Characteristic . | Patients . |
|---|---|
| N = 1132 . | |
| Age (years) | 70.1 ± 8.9 |
| Male sex | 854 (75.4%) |
| Body surface area (m2) | 2.0 ± 0.2 |
| NYHA class | |
| I | 126 (11.1%) |
| II | 533 (47.1%) |
| III | 451 (39.8%) |
| IV | 22 (1.9%) |
| STS risk of mortality (%) | 2.0 ± 1.4 |
| History of atrial fibrillation | 119/1125 (10.6%) |
| Paroxysmal | 72/1125 (6.4%) |
| Persistent | 32/1125 (2.8%) |
| Long-standing persistent | 15/1125 (1.3%) |
| Unknown | 7 |
| Congestive heart failure | 224 (19.8%) |
| Coronary artery disease | 496 (43.8%) |
| Diabetes | 303 (26.8%) |
| Dyslipidaemia | 698 (61.7%) |
| Prior endocarditis | 4 (0.4%) |
| Hypertension | 861 (76.1%) |
| Left ventricular hypertrophy | 459 (40.5%) |
| Myocardial infarction | 100 (8.8%) |
| Renal dysfunction/insufficiency | 120 (10.6%) |
| Stroke/cerebrovascular accident | 46 (4.1%) |
| Transient ischaemic attack | 61 (5.4%) |
| Coronary artery bypass | 25 (2.2%) |
| Percutaneous coronary intervention | 161 (14.2%) |
| Stent implanted | 153 (13.5%) |
| Implanted cardiac device (i.e. pacemaker or defibrillator) | 39 (3.4%) |
| Previous open-heart surgerya | 40 (3.5%) |
Data are mean ± SD or n (%).
No patient had >1 prior open-heart surgery.
NYHA: New York Heart Association; SD: standard deviation; STS: Society of Thoracic Surgeons.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
